Merck & Co Inc
Microsoft and Nvidia finally became cheap enough for this value investor – and he plans to buy any dips
One value investor who envied the yearslong rise of artificial intelligence darlings Microsoft and Nvidia has finally found their prices compelling enough to snap up earlier this year. He also said he will be buying any dips. Chris Grisanti, chief market strategist at MAI Capital Management, oversees the MAI Focused Equity Strategy, which has $3 […]
Read More
Stocks making the biggest moves midday: Sandisk, Micron, Verizon, AMD, GE Vernova and more
Check out the companies making the biggest moves in midday trading: Sandisk , Micron — Memory stocks were trading higher after Melius Research highlighted the group and said the artificial intelligence cycle should keep demand high for memory through the end of the decade. The analysts said that investors will likely be willing to pay […]
Read More
WHCD shooting, DOJ ends Powell probe, Musk vs. Altman and more in Morning Squawk
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Good morning. We have a big week ahead of us: In addition to earnings reports from key automakers and five of the “Magnificent Seven,” the Federal Reserve will make its next monetary policy decision and the trial between Elon Musk and Sam […]
Read More
Stocks making the biggest moves premarket: Qualcomm, Domino’s Pizza, Adobe & more
Check out the companies making the biggest moves premarket: Qualcomm , Apple — The chipmaker surged more than 12% after TF International Securities analyst Ming-Chi Kuo said in a post on X that OpenAI is working with Qualcomm to develop smartphone processors. Apple, the iPhone maker, slipped 1.5% on the report of a potential new […]
Read More
Sun Pharma shares jump 5% as India’s largest drugmaker to buy U.S. firm Organon in $11.75 billion deal
SHANGHAI, CHINA – NOVEMBER 05: People visit the booth of Organon during the 7th China International Import Expo (CIIE) at the National Exhibition and Convention Center (Shanghai) on November 5, 2024 in Shanghai, China. The 7th China International Import Expo (CIIE) kicked off in Shanghai on November 5. (Photo by Tang Yanjun/China News Service/VCG via […]
Read More
Trump nominates Erica Schwartz as CDC director amid turmoil around leadership, vaccine policy
Rear Admiral Erica G. Schwartz. U.S. Department of Health and Human Services President Donald Trump on Thursday nominated Erica Schwartz to serve as director of the Centers for Disease Control and Prevention, concluding a monthslong effort to choose a permanent leader of the embattled health agency. Schwartz will have to be confirmed by the Senate, […]
Read More
Trump policies, China’s biotech boom are ending Europe’s pharma powerhouse era
Boxes of medication are seen on the shelves of the Keencare pharmacy, a member of the Green Light Group, on September 19, 2024 in London, England. Leon Neal | Getty Images News | Getty Images Once the go-to location for global drugmakers, Europe is now being squeezed by President Donald Trump’s aggressive trade and drug-pricing […]
Read More
Trump tariff fallout: Some industries grapple with lingering effects one year later
A year after President Donald Trump declared his “liberation day” and imposed sweeping tariffs on imports, kicking off a wave of economic and political uncertainty, some companies are still feeling the effects. While some industries have emerged largely unscathed — having weathered twists and turns of several tariff iterations — others, such as retail, automotive, […]
Read More
Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs
The Trump administration is preparing to impose new tariffs on branded drugs from pharmaceutical companies that have not struck landmark deals with the president to lower their U.S. drug prices, CNBC has learned. Patented medications and their active ingredients would be hit with a 100% tariff, according to a draft of the document obtained by […]
Read More
Novartis shells out $2 billion for immunology biotech Excellergy, in second multi-billion dollar deal in a week
A sign of Swiss pharmaceutical giant Novartis is seen on the top of a building at Novartis Campus in Basel, northern Switzerland, on Sept. 9, 2025. Fabrice Coffrini | AFP | Getty Images Novartis is planning to buy U.S.-based biotech Excellergy for up to $2 billion, betting on a next-generation allergy treatment that may prove […]
Read More